Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry
Cytek Biosciences, Inc. (CTKB)
Company Research
Source: GlobeNewswire
FREMONT, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amid the reduction of various government grant programs and global economic challenges that have tightened research funding, Cytek Biosciences, Inc. (Nasdaq: CTKB) is taking steps to ensure critical scientific research can continue. Joining the International Society for Advancement of Cytometry’s (ISAC) mission to advance global availability and adoption of cytometry technology and empower scientists, Cytek has launched a two-part research support initiative to make cell analysis more accessible. ISAC President Jessica P. Houston commended these initiatives. “Cytek’s commitment to expanding access to advanced cytometry is a vital contribution to global public health. By supporting under-resourced labs, they’re helping ensure that essential research can continue – regardless of geography or funding. I applaud this meaningful step toward greater scientific equity.” As the first phase of this initiative, Cytek is awarding a three-las
Show less
Read more
Impact Snapshot
Event Time:
CTKB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CTKB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CTKB alerts
High impacting Cytek Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
CTKB
News
- Cytek Biosciences (NASDAQ:CTKB) was given a new $6.00 price target on by analysts at Morgan Stanley.MarketBeat
- Cytek Biosciences Is A Speculative Buy On Recurring Revenue Growth [Seeking Alpha]Seeking Alpha
- Cytek Biosciences (CTKB): Evaluating Valuation After TIME's 2026 Growth Leaders Recognition and Recurring Revenue Momentum [Yahoo! Finance]Yahoo! Finance
- TIME Recognizes Cytek® Biosciences as One of America's Growth Leaders of 2026 [Yahoo! Finance]Yahoo! Finance
- TIME Recognizes Cytek® Biosciences as One of America’s Growth Leaders of 2026GlobeNewswire
CTKB
Earnings
- 11/5/25 - Beat
CTKB
Sec Filings
- 11/20/25 - Form 4
- 11/20/25 - Form 4
- 11/20/25 - Form 4
- CTKB's page on the SEC website